Related Experiment Video
Updated: May 31, 2025

Functional Assessment of Intestinal Permeability and Neutrophil Transepithelial Migration in Mice using a Standardized Intestinal Loop Model
Published on: February 11, 2021
Disrupting of IGF2BP3-stabilized CLDN11 mRNA by TNF-α increases intestinal permeability in obesity-related severe
Lihui Lin1, Yansong Lin2, Xianwen Guo1
1Division of Gastroenterology, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, P. R. China.
Background:
Obesity is a significant risk factor for severe acute pancreatitis (SAP) and is typically associated with increased intestinal permeability. Understanding the role of specific molecules can help reduce the risk of developing SAP. Claudin 11 (CLDN11), a member of the Claudin family, regulates the permeability of various internal barriers. However, the role and mechanism of CLDN11 in the intestinal permeability of obesity-related SAP remain unclear.
Methods:
We evaluated intestinal permeability and the expression of CLDN11 in experimental obesity-related SAP. A recombinant adeno-associated virus carrying CLDN11 was used to treat experimental obesity-related SAP. The interaction between CLDN11 mRNA and insulin-like growth factor 2 mRNA-binding protein 3 (IGF2BP3) protein was predicted through bioinformatics analysis and validated by RNA immunoprecipitation and RNA pull-down assay. Additionally, tumor necrosis factor-α (TNF-α) treatment in Caco-2 cells was conducted, and the IGF2BP3/CLDN11 axis was detected. Moreover, we conducted anti-TNFα therapy and evaluated intestinal permeability and pancreatic inflammation in experimental obesity-related SAP.
Results:
Downregulation of CLDN11 was observed in the intestinal epithelial cells of experimental obesity-related SAP. When the expression of CLDN11 in intestinal epithelial cells of experimental obesity-related SAP was increased exogenously, intestinal epithelial permeability and pancreatic inflammation were relieved. Overexpression of CLDN11 reduced the paracellular permeability of Caco-2 monolayer cells, while knockdown of CLDN11 increased it. IGF2BP3 bound to and regulated the stability of CLDN11 mRNA. TNF-α treatment downregulated IGF2BP3 and CLDN11 in vitro. Anti-TNFα therapy reduced intestinal permeability, alleviated pancreatitis, and improved the expression of IGF2BP3 and CLDN11 in intestinal epithelial cells in experimental obesity-related SAP.
Conclusion:
CLDN11 regulates intestinal permeability in obesity-related SAP. Mechanistically, an increase in TNF-α impaired the stability of IGF2BP3-dependent CLDN11 mRNA in obesity-related SAP.
Insights
Claudin 11 (CLDN11) helps regulate intestinal permeability in obesity-related severe acute pancreatitis (SAP). Tumor necrosis factor-alpha (TNF-α) disrupts this by reducing CLDN11 mRNA stability, leading to increased intestinal permeability and pancreatitis.
Area of Science:
- Gastroenterology
- Molecular Biology
- Pathophysiology
Background:
- Obesity is a key risk factor for severe acute pancreatitis (SAP), often linked to increased intestinal permeability.
- Claudin 11 (CLDN11), a tight junction protein, influences barrier function, but its role in obesity-related SAP intestinal permeability is unknown.
Purpose of the Study:
- To investigate the role and mechanism of CLDN11 in intestinal permeability during obesity-related SAP.
- To explore the potential of targeting the CLDN11 pathway for therapeutic intervention.
Main Methods:
- Evaluated intestinal permeability and CLDN11 expression in experimental obesity-related SAP models.
- Utilized recombinant adeno-associated virus for CLDN11 manipulation and assessed its effects.
- Investigated the interaction between CLDN11 mRNA and IGF2BP3 protein using bioinformatics and experimental validation.
- Examined the impact of tumor necrosis factor-alpha (TNF-α) on the IGF2BP3/CLDN11 axis in Caco-2 cells and in vivo.
Main Results:
- CLDN11 expression was downregulated in intestinal epithelial cells of experimental obesity-related SAP.
- Exogenous CLDN11 restoration reduced intestinal epithelial permeability and pancreatic inflammation.
- Overexpression of CLDN11 decreased paracellular permeability, while knockdown increased it.
- IGF2BP3 was identified as a regulator of CLDN11 mRNA stability.
- TNF-α downregulated both IGF2BP3 and CLDN11; anti-TNFα therapy improved intestinal barrier function and reduced pancreatitis.
Conclusions:
- CLDN11 plays a crucial role in regulating intestinal permeability in obesity-related SAP.
- Increased TNF-α impairs the stability of IGF2BP3-dependent CLDN11 mRNA, contributing to the pathophysiology of obesity-related SAP.
Related Concept Videos
Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Acute Pancreatitis I: Introduction
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...

